| Chapter title |
The Treatment of Venous Thromboembolism in Patients with Cancer
|
|---|---|
| Chapter number | 111 |
| Book title |
Thrombosis and Embolism: from Research to Clinical Practice
|
| Published in |
Advances in experimental medicine and biology, September 2016
|
| DOI | 10.1007/5584_2016_111 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-922107-6, 978-3-31-922108-3
|
| Authors |
Paolo Prandoni M.D., Ph.D., Paolo Prandoni, Prandoni, Paolo |
| Editors |
Md. Shahidul Islam |
| Abstract |
Venous thromboembolism (VTE) is a frequent complication in cancer patients and represents an important cause of morbidity and mortality. The treatment of VTE complications in cancer patients remains a difficult clinical task. Low-molecular-weight heparins (LMWH) are the cornerstone of VTE treatment in cancer patients, including the treatment of catheter-related thrombosis. LMWH dose adjustment is effective in treating recurrent thrombosis and in patients with bleeding or thrombocytopenia. The duration of treatment is dependent on several factors that need to be individually evaluated. The novel anticoagulants should be investigated more carefully before being routinely implemented in the treatment of cancer-associated VTE. Incidentally detected isolated sub-segmental pulmonary embolism is unlikely to require systematic full-dose anticoagulation. Whether the long-term use of LMWHs has the potential to prolong survival in subgroups of cancer patients requires further investigations. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Denmark | 1 | 2% |
| Unknown | 57 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 17% |
| Student > Master | 7 | 12% |
| Student > Bachelor | 6 | 10% |
| Other | 4 | 7% |
| Researcher | 4 | 7% |
| Other | 10 | 17% |
| Unknown | 18 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 49% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Veterinary Science and Veterinary Medicine | 1 | 2% |
| Agricultural and Biological Sciences | 1 | 2% |
| Nursing and Health Professions | 1 | 2% |
| Other | 2 | 3% |
| Unknown | 23 | 39% |